Gamma Knife Center, Department of Neurosurgery, ETZ Hospital, Tilburg.
Eindhoven University of Technology, Eindhoven.
Otol Neurotol. 2020 Dec;41(10):e1321-e1327. doi: 10.1097/MAO.0000000000002886.
Stereotactic radiosurgery (SRS) is one of the treatment modalities for vestibular schwannomas (VSs). However, tumor progression can still occur after treatment. Currently, it remains unknown how to predict long-term SRS treatment outcome. This study investigates possible magnetic resonance imaging (MRI)-based predictors of long-term tumor control following SRS.
Retrospective cohort study.
Tertiary referral center.
Analysis was performed on a database containing 735 patients with unilateral VS, treated with SRS between June 2002 and December 2014. Using strict volumetric criteria for long-term tumor control and tumor progression, a total of 85 patients were included for tumor texture analysis.
INTERVENTION(S): All patients underwent SRS and had at least 2 years of follow-up.
MAIN OUTCOME MEASURE(S): Quantitative tumor texture features were extracted from conventional MRI scans. These features were supplied to a machine learning stage to train prediction models. Prediction accuracy, sensitivity, specificity, and area under the receiver operating curve (AUC) are evaluated.
Gray-level co-occurrence matrices, which capture statistics from specific MRI tumor texture features, obtained the best prediction scores: 0.77 accuracy, 0.71 sensitivity, 0.83 specificity, and 0.93 AUC. These prediction scores further improved to 0.83, 0.83, 0.82, and 0.99, respectively, for tumors larger than 5 cm.
Results of this study show the feasibility of predicting the long-term SRS treatment response of VS tumors on an individual basis, using MRI-based tumor texture features. These results can be exploited for further research into creating a clinical decision support system, facilitating physicians, and patients to select a personalized optimal treatment strategy.
立体定向放射外科(SRS)是治疗前庭神经鞘瘤(VS)的方法之一。然而,治疗后肿瘤仍可能进展。目前,尚不清楚如何预测 SRS 治疗的长期效果。本研究探讨了 SRS 治疗后长期肿瘤控制的可能基于磁共振成像(MRI)的预测因素。
回顾性队列研究。
三级转诊中心。
分析了一个数据库,其中包含 735 例单侧 VS 患者,他们于 2002 年 6 月至 2014 年 12 月接受了 SRS 治疗。使用长期肿瘤控制和肿瘤进展的严格体积标准,共有 85 例患者被纳入肿瘤纹理分析。
所有患者均接受 SRS 治疗,并进行了至少 2 年的随访。
从常规 MRI 扫描中提取定量肿瘤纹理特征。这些特征被提供给机器学习阶段,以训练预测模型。评估预测准确性、敏感性、特异性和接收器操作曲线(AUC)下的面积。
灰度共生矩阵,它从特定的 MRI 肿瘤纹理特征中捕获统计信息,获得了最佳的预测评分:0.77 准确性、0.71 敏感性、0.83 特异性和 0.93 AUC。对于大于 5cm 的肿瘤,这些预测评分进一步提高至 0.83、0.83、0.82 和 0.99。
本研究结果表明,使用基于 MRI 的肿瘤纹理特征,对 VS 肿瘤的 SRS 治疗反应进行个体预测是可行的。这些结果可用于进一步研究创建临床决策支持系统,以帮助医生和患者选择个性化的最佳治疗策略。